Navigation Links
New Poll From Lake Research Shows Americans Support Allowing Physicians to Own and Operate Hospitals
Date:3/14/2008

> for patients who can make them the most profit. This could drive up

the costs for all of us.

Allowed to Own: Other people say physicians SHOULD be able to own and

operate the hospitals where they work because in those hospitals they

can provide better care for their patients. For too long, decisions

about patient care have been made by administrators and insurance

companies, even though doctors actually provide the care. If doctors

own hospitals they can make the decisions based on what their patients

need.

(5) Question wording: Thinking about the proposal in Congress to prohibit

physicians from owning and operating the hospitals in which they work,

how would you want your member of Congress to vote on this proposal?

Would you want your member of congress to vote to prohibit physicians

from owning and operating hospitals or vote to allow physicians to own

and operate hospitals?


'/>"/>
SOURCE Lake Research Partners
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
5. New research shows how chronic stress worsens neurodegenerative disease course
6. New research explores newborn in-hospital weight loss
7. Research may unlock mystery of autisms origin in the brain
8. Bipolar disorder relapses halved by Melbourne researchers
9. HIVs impact in Zimbabwe explored in new research
10. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
11. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...taract surgery is higher in patients who have take...rged prostate.// According to the 3 medical assoc...e American Society of Cataract and Refractive Surg...tion, mentioning the use of drugs like Flomax (tam...
...a seriously ill toddler his vital heart monitor du... child who suffers from a rare heart condition has...ous attitude. Stephen Leckey has also appealed to ...ess crime to return the monitor that is an vital p...
...sotretinoin has been found to have more dangerous ... even though it is an effective medication for the...as Accutane in the US and as Roaccutane in UK, and...own to clear up severe acne and prevent scarring, ...
...ng in Australia has found that many South Australi...ving regular screenings// through pap smears. The ...ring 2001-04 more than the 66 in 1997-2000. In th...e was highest with 15 deaths during the period. Pr...
Other Medicine News:Health News:Alpha-blockers call for modification in cataract surgery 2Health News:Alpha-blockers call for modification in cataract surgery 3Health News:Callous Thieves Rob An Seriously Ill Child Of His Vital Heart Machine 2Health News:Acne Drug Found To Cause More Harm than Good 2
(Date:10/7/2008)...e-FirstCall/ - Burcon NutraScience,Corporation (TS...Supertein(TM) canola protein isolates are GRAS (Ge... in a variety of food and beverage,applications. T...n,independent evaluation by a panel of qualified e...utritional sciences, food allergies and pediatric,...
(Date:10/7/2008)...at ACG Annual Scientific Meeting -, ORLANDO, Fla....ceuticals, Inc. (formerly Microbia, Inc.) and Fore...d the presentation of results from a Phase,2b stud...20 patients with,irritable bowel syndrome with con...that once- daily oral dosing of linaclotide, acros...
(Date:10/7/2008)...e-FirstCall/ -- Ardea Biosciences, Inc.,(Nasdaq: ...A119, a Potent,and Highly Selective MEK1/2 Inhibit...- induced Chronic Colitis in Mice," was presented ...2008 Annual Meeting in Orlando,Florida. The poste...,RDEA119, the Company,s lead mitogen-activated ERK...
(Date:10/6/2008)...ewswire-FirstCall/ -- Pharmasset, Inc.,(Nasdaq: V... joining the,Company as Vice President of Investor... will be responsible for all investor relations,fu...l Officer Kurt,Leutzinger., Most recently, Dr. Sm...Analyst at JPMorgan Securities, and has been an an...
Breaking Medicine Technology:Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3New Drug Application for Tolvaptan Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia Accepted by the U S Fo 2362 1New Drug Application for Tolvaptan Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia Accepted by the U S Fo 2362 2New Drug Application for Tolvaptan Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia Accepted by the U S Fo 2362 3Senesco Technologies Closes on Additional 244 0 Million of Previously Announced Financing 2360 1Senesco Technologies Closes on Additional 244 0 Million of Previously Announced Financing 2360 2Senesco Technologies Closes on Additional 244 0 Million of Previously Announced Financing 2360 3Supplemental New Drug Application for PREZISTA 28TM 29 Submitted to U S Food and Drug Administration 1117 1Supplemental New Drug Application for PREZISTA 28TM 29 Submitted to U S Food and Drug Administration 1117 2Supplemental New Drug Application for PREZISTA 28TM 29 Submitted to U S Food and Drug Administration 1117 3Supplemental New Drug Application for PREZISTA 28TM 29 Submitted to U S Food and Drug Administration 1117 4Supplemental New Drug Application for PREZISTA 28TM 29 Submitted to U S Food and Drug Administration 1117 5FDA to Extend Review of Data Quality Submission for Genasense 28R 29 in Melanoma 1115 1FDA to Extend Review of Data Quality Submission for Genasense 28R 29 in Melanoma 1115 2FDA to Extend Review of Data Quality Submission for Genasense 28R 29 in Melanoma 1115 3
...a Trial to 9 mg Dosage,Level, HOPKINTON, Mass., Ap... Sciences announced today that clinical data on it...ented in the Neurotrauma,and Critical Care Scienti...ican Association of Neurological Surgeons (AANS) i...s of the Cethrin Phase I/IIa,Prospective Clinical ...
...ire-FirstCall/ -- Kosan,Biosciences Incorporated t...t-generation epothilone, showing a high level of,a...and safety,profile in a broad range of in vitro te...hemically engineered to have a favorable,tissue di... to,result in excellent tumor penetration and a lo...
Other Medicine Technology:Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase,I/IIa 6-Month Results at 75th Annual Meeting of the American,Association of Neurological Surgeons 2Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase,I/IIa 6-Month Results at 75th Annual Meeting of the American,Association of Neurological Surgeons 3Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase,I/IIa 6-Month Results at 75th Annual Meeting of the American,Association of Neurological Surgeons 4Kosan Presents Preclinical Antitumor and Safety Data On,Next-Generation Epothilone KOS-1803 at AACR 2Kosan Presents Preclinical Antitumor and Safety Data On,Next-Generation Epothilone KOS-1803 at AACR 3
... of deflectable curve catheters designed to specif...r patients with small anatomies. Each catheter is ... the finest materials. A unique multi-step process...ion technologies results in the excellent torque a...
... of fixed curve catheters designed to specifically...ents with small anatomies. Each catheter is handcr...inest materials. A unique multi-step process that ...chnologies results in the excellent torque and fle...
4Fr, 5Fr & 6Fr diagnostic electrophysiology catheters with fixed curves.
Inquiry 4Fr, 5Fr and 6Fr diagnostic electrophysiology catheters offer simple, precise distal control with it's patented Easy-Hand steering mechanism.
Medicine Products: